DISEASE INDICATIONS: Psoriatic Arthritis, Rheumatoid Arthritis

MANUFACTURER: AbbVie Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Rinvoq, with the active ingredient upadacitinib, is a prescription medication that belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It is used to treat various inflammatory conditions, particularly autoimmune diseases like rheumatoid arthritis, where the immune system mistakenly attacks healthy joints and tissues, leading to pain, swelling, and joint damage.